Primary resistance mutations to fusion inhibitors and polymorphisms in gp41 sequences of HIV-1 non-B subtypes and recombinants

AIDS. 2003 May 2;17(7):1083-6. doi: 10.1097/00002030-200305020-00020.

Abstract

Primary resistance mutations to fusion inhibitors and polymorphisms in gp41 sequences of non-B subtypes and recombinant HIV-1 isolates were analysed. L91H to RPR103611 was detected in one DGpol/Denv/Dgp41 recombinant; L9F and K144R, rarely reported previously, were frequent in the B region of CRF14_BG recombinants. V194I and V318A, not described in the G subtype, were detected in the G region of BG recombinants and in G subtype viruses that also show the rare mutations T115L, M118V and K90R.

Publication types

  • Research Support, Non-U.S. Gov't

MeSH terms

  • Anti-HIV Agents / therapeutic use*
  • Drug Resistance, Viral / genetics*
  • Enfuvirtide
  • HIV Envelope Protein gp41 / genetics*
  • HIV Envelope Protein gp41 / therapeutic use
  • HIV Fusion Inhibitors / therapeutic use*
  • HIV Infections / genetics*
  • Humans
  • Male
  • Mutation / genetics*
  • Peptide Fragments / therapeutic use
  • Polymorphism, Genetic

Substances

  • Anti-HIV Agents
  • HIV Envelope Protein gp41
  • HIV Fusion Inhibitors
  • Peptide Fragments
  • Enfuvirtide